AzTrials
AzTrials

SARS-CoV-2NCT04753463

Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland

An observational study of SARS-CoV-2, run by Medical University of Bialystok at 2 sites in Poland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of study is to investigate the impact of SARS-CoV-2 on ophthalmology training programs among residents. To the best of our knowledge this study is the first of its kind in Poland. Read more about this study

Who is it for?
Ages 25 to 35 years
Conditions the study is for
SARS-CoV-2
What is being tested?
Survey
How many people
126 participants
Where
2 sitesPoland
Study dates
15 Mar 2021to 15 Apr 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 35 years
  • All sexes
  • Adult

Study population: Residents of ophthalmology (male and female), in the age of 25-35 working on ophthalmology departments

Who may be able to join

  • male and female in the age of 25-35 during residence training

Who cannot join

  • lack of consent for participating in survey

Trial locations and contacts

2 sites in 1 country.

Poland2 sites
  • Medical University

    Bialystok, 15-089

  • Ophthalmology Clinic Medical University of Bialystok

    Bialystok, 15-089

Other trials in Poland

About this study

The aim of study is to investigate the impact of SARS-CoV-2 on ophthalmology training programs among residents. To the best of our knowledge this study is the first of its kind in Poland. The impact of COVID-19 on ophthalmology training programs is largely unknown as there are only few studies assessing the above issue from the resident's point of view.

Read the detailed description

The novel coronavirus SARS-CoV-2, responsible for Coronavirus Disease 2019 (COVID-19), was first identified at the end of the year 2019 in Wuhan (China). A rapid spread of the disease resulted in global threat to public health. On 11 March 2020 the World Health Organization (WHO) announced the state of pandemic. In Poland, the first confirmed case of COVID-19 was reported on 4 March 2020 and subsequent growing number of patients has placed tremendous strain on healthcare system. The crisis situation prompted immediate action to divert healthcare resources for the treatment of patients with COVID-19 and to limit the spread of the infection. In accordance with the decision of the Minister of Health of March 13th, 2020, more than twenty hospitals were established to admit only the SARS-CoV-2 affected patients. Moreover, all hospitals were recommended to limit their planned activity and to perform only urgent and emergency services.

The investigators hypothesize that those changes in healthcare system and restrictions established in public area during pandemic caused significant difficulties in residency training considering clinical and surgical practice as well as didactic activities. In spite of gradual reopening the routine services over the last few months, social distancing rules are still in force. Accordingly, different methods of virtual teaching were introduced including, inter alia, organisation of courses, lectures and conferences in form of on-line meetings.

The aim of current study is to investigate the impact of SARS-CoV-2 on ophthalmology training programs among residents. To the best of our knowledge this study is the first of its kind in Poland. The impact of COVID-19 on ophthalmology training programs is largely unknown as there are only few studies assessing the above issue from the resident's point of view.

The investigators believe that this investigations will address this gap in the literature and could be used to initiate the new solutions in order to maintain successful residency training during pandemic. Opinions regarding the efficiency of e-learning methods and on-line meetings may be crucial to innovate the conventional teaching way permanently in the future.

Conditions
SARS-CoV-2
Being tested
Survey
Keywords
Residents training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SurveyOther

    The on-line questionnaire which assess the subjective feelings of residents of pandemic impact on ophthalmology training programs

Study groups in NCT04753463
Study groupRoleWhat they receive
Residents of Ophthalmology working on COVID-19 departmentsResidents of ophthalmology working on COVID-19 departments and dealing with SARS-CoV-2 positive patients
Receives: Other: Survey
Residents of Ophthalmology working on general ophthalmic departmentsResidents of Ophthalmology working on general ophthalmic departments and not dealing with SARS-CoV-2 positive patients
Receives: Other: Survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. questionnaire assessing the incidence of disturbance of COVID-19 pandemic on ophthalmology training programs among residents

    the opinion of ophthalmology training programs among residents assessed with the questionnaire collecting demographics (age, gender), domicile (state, union territory), current professional status (in training or practising), type of practice (solo, group, institutional, governmental, non-governmental), marital status (married, single), impact of COVID-19 on their training or ophthalmology practice, and impact on income and ability to meet living expense

    Measured: 1 month

Secondary outcomes (2)
  1. questionnaire assessing the negative impact of COVID-19 pandemic on mental health among ophthalmology residents

    the opinion on impact for mental health among residents assessed with the Patient Health Questionnaire-9 (PHQ-9). PHQ-9 is a selfreport measure that is used to assess the severity of depression over the prior 2 weeks. Response to the nine questions are graded as 0 (not at all), 1 (several days), 2 (more than half the days), and 3 (nearly every day). The total score of PHQ-9 that categorizes depression is as follows: minimal/no depression (0-4), mild depression (5-9), moderate depression (10-14), or severe depression (15-21).

    Measured: 1 month

  2. questionnaire assessing the attitude on COVID-19 vaccination of ophthalmology residents

    the attitude towards the vaccination against the SARS-CoV-2 among residents assessed with the questionnaire with open questions about the willingness of taking the vaccination

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Feb 2021
  2. Study start15 Mar 2021
  3. Primary completion28 Mar 2021
  4. Study completion15 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04753463
Sponsor's protocol ID
1775
Status last verified
Sep 2021
First submitted
4 Feb 2021
Last updated
28 Sep 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participant data that underlie the results reported in this article are available upon reasonable request for academic and non-commercial purposes beginning with article publication and ending 5 years thereafter. Proposals should be submitted to joannakonopinska@o2.pl for review and approval by an internal steering committee. Qualified researchers with reasonable proposals will be provided access to the data along with the redacted study protocol and statistical analysis plan to achieve the specified aims in their approved proposal after signing a data access agreement.

Publications

  • Silva N, Laiginhas R, Meireles A, Barbosa Breda J. Impact of the COVID-19 Pandemic on Ophthalmology Residency Training in Portugal. Acta Med Port. 2020 Oct 1;33(10):640-648. doi: 10.20344/amp.14341. Epub 2020 Sep 10.

    PubMed 32914750
  • Mishra D, Nair AG, Gandhi RA, Gogate PJ, Mathur S, Bhushan P, Srivastav T, Singh H, Sinha BP, Singh MK. The impact of COVID-19 related lockdown on ophthalmology training programs in India - Outcomes of a survey. Indian J Ophthalmol. 2020 Jun;68(6):999-1004. doi: 10.4103/ijo.IJO_1067_20.

    PubMed 32461413
  • El-Saied HMA, Salah Eddin Abdelhakim MA. Impact of COVID-19 Pandemic on Young Ophthalmologists in Cairo University Hospitals. Semin Ophthalmol. 2020 Aug 17;35(5-6):296-306. doi: 10.1080/08820538.2020.1826046. Epub 2020 Oct 5.

    PubMed 33017198

Questions about this trial

What is this clinical trial studying?

An observational study of SARS-CoV-2, run by Medical University of Bialystok at 2 sites in Poland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Poland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

questionnaire assessing the incidence of disturbance of COVID-19 pandemic on ophthalmology training programs among residents (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04753463, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in